The Same Players, Better Results: How Experience and Growth Factors Better Usage Improve Peripheral Blood Stem Cells Collection Outcome
Georgios Karavalakis(University of California, Riverside), Damianos Sotiropoulos(G. Papanikolaou General Hospital), Christos Demosthenous(G. Papanikolaou General Hospital), Savvas Gounopoulos(G. Papanikolaou General Hospital), Despina Papadopoulou(G. Papanikolaou General Hospital), Eleni Paphianou(G. Papanikolaou General Hospital), Ioanna Sakellari(G. Papanikolaou General Hospital), Ioannis Batsis(G. Papanikolaou General Hospital), Thomas Chatzikonstantinou(G. Papanikolaou General Hospital), George Zdoupas(G. Papanikolaou General Hospital), Panagiota Karabasilidou(G. Papanikolaou General Hospital), Asimina Bouinta(G. Papanikolaou General Hospital), Despina Mallouri(G. Papanikolaou General Hospital), Nikolaos Spyridis(G. Papanikolaou General Hospital)
Cited by 0
Related Papers
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
|Leukemia|2021|94
Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks
|Journal of Cellular and Molecular Medicine|2022|90
Genetic justification of severe COVID-19 using a rigorous algorithm
|Clinical Immunology|2021|63
Beta-thalassemia: renal complications and mechanisms: a narrative review
|Hematology|2019|62